Literature DB >> 7950159

Primary systemic amyloidosis leading to advanced renal and cardiac involvement in a 30-year old man.

I Spyridopoulos1, U Helber, W Voelker, P E Huppert, H V Gärtner, J G Saal, H M Hoffmeister, T Risler.   

Abstract

The case of a 30-year-old man with primary systemic amyloidosis is reported. Three months prior to admission the patient developed fever, night sweats, dyspnea, and bilateral ankle swelling. Recurrent left-sided pleural effusion led to further investigation when massive proteinuria with free monoclonal lambda chains in the urine became evident. Abdominal subcutaneous fat aspiration and renal biopsy confirmed the diagnosis of amyloidosis. Bone marrow biopsy and bone scan did not reveal multiple myeloma. Echocardiography showed a sparkling texture of the interventricular septum. Pulsed-wave Doppler recording of the left ventricular inflow profile showed the pattern of advanced cardiac amyloidosis consistent with markedly impaired diastolic heart function. Electrocardiogram-gated magnetic resonance imaging was carried out for noninvasive evaluation of cardiac function. The patient was started on repeated courses of melphalan, prednisone, and colchicine therapy. Despite increasing deterioration of renal function the therapy was tolerated quite well, and the patient is still alive 10 months after initial diagnosis. Although very rare in this age, primary systemic amyloidosis should be considered as a cause of pleural effusion, proteinuria, and congestive heart failure and should lead to further investigation.

Entities:  

Mesh:

Year:  1994        PMID: 7950159     DOI: 10.1007/bf00180522

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  10 in total

1.  Prognostic value of urinary protein in primary systemic amyloidosis (AL).

Authors:  M A Gertz; R A Kyle
Journal:  Am J Clin Pathol       Date:  1990-09       Impact factor: 2.493

2.  Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.

Authors:  M D Benson
Journal:  Arthritis Rheum       Date:  1986-05

3.  Immunochemical typing of amyloid deposits after microextraction from biopsies.

Authors:  R P Linke
Journal:  Appl Pathol       Date:  1985

Review 4.  Primary systemic amyloidosis--a diagnostic primer.

Authors:  M A Gertz; R A Kyle
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

5.  Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.

Authors:  J D Hosenpud; T DeMarco; O H Frazier; B P Griffith; B F Uretsky; A H Menkis; J B O'Connell; M T Olivari; H A Valantine
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

6.  Amyloidosis with pleural involvement.

Authors:  D R Graham; D Ahmad
Journal:  Eur Respir J       Date:  1988-06       Impact factor: 16.671

7.  Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973).

Authors:  A S Cohen; A Rubinow; J J Anderson; M Skinner; J H Mason; C Libbey; H Kayne
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

8.  Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.

Authors:  M A Gertz; R A Kyle; W M O'Fallon
Journal:  Arch Intern Med       Date:  1992-11

9.  Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.

Authors:  L Cueto-Garcia; G S Reeder; R A Kyle; D L Wood; J B Seward; J Naessens; K P Offord; P R Greipp; W D Edwards; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

10.  Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.

Authors:  A L Klein; L K Hatle; C P Taliercio; J K Oh; R A Kyle; M A Gertz; K R Bailey; J B Seward; A J Tajik
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.